Showing results (281-290 of 336) with videos related to
Sort By:
Pageof 34
Cancer Science|December 15, 2023
Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816Tetsuya Mitsudomi, Hiroyuki Ito, Morihito Okada, et al.Thoracic Cancer|February 13, 2025
Detection of Overlooked Rare EGFR Mutations in Non-small Cell Lung Cancer Using Multigene TestingNaoki Shiraishi, Takayuki Takahama, Kazuko Sakai, et al.The Journal of Clinical Investigation|June 10, 2014
CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistanceKang-Seo Park, Mark Raffeld, Yong Wha Moon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2021
Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non-Small-Cell Lung Cancer With <i>EGFR</i> Mutation (IMPACT)Hirohito Tada, Tetsuya Mitsudomi, Toshihiro Misumi, et al.The Journal of Thoracic and Cardiovascular Surgery|July 18, 2025
Clinical utility of the 5-point visual Deauville score for preoperative evaluation in stage I non-small cell lung cancer: A multicenter retrospective studyTomoyo Fukami, Akira Hamada, Kenichi Suda, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2023
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLCNaoki Haratake, Hiroki Ozawa, Yoshihiro Morimoto, et al.European Journal of Cancer (Oxford, England : 1990)|September 27, 2017
Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinomaTomonari Kinoshita, Chie Kudo-Saito, Reiko Muramatsu, et al.Journal of the National Cancer Institute|April 5, 2017
Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall SurvivalChee Khoon Lee, Lucy Davies, Yi-Long Wu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
Epidermal growth factor receptor inhibition in lung cancer: status 2012Fred R Hirsch, Pasi A Jänne, Wilfried E Eberhardt, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2022
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in AsiaTetsuya Mitsudomi, Daniel Tan, James Chih-Hsin Yang, et al.Pageof 34